What are the Mounjaro stages and what changes at each one?

Why does Mounjaro start at 2.5 mg if that isn't the therapeutic dose?

The 2.5 mg starting stage often surprises people. It's not designed to produce meaningful weight loss, and it isn't a weaker version of what comes later. Its job is adjustment. Tirzepatide slows gastric emptying and significantly reduces appetite, both effects that, introduced abruptly at a higher dose, would likely cause considerable nausea. Starting low gives your gut the time it needs to adapt to a new hormonal signal before the dose increases.

Think of the first pen as your system finding its footing. Most people notice mild gastrointestinal changes (some nausea, perhaps a little less appetite than usual) but tolerate this stage well. The NHS tirzepatide information page confirms this staged approach and lists what to expect at each phase. After four weeks, if you're tolerating 2.5 mg comfortably, your prescriber will typically move you to 5 mg, where the appetite-suppressing and metabolic effects begin in earnest.

It's also worth knowing that some people stay at a given stage longer than four weeks if they're experiencing side effects, or if their prescriber judges it clinically appropriate. The schedule is a guide, not a contract. You can read more about how tirzepatide works at a pharmacological level on the tirzepatide overview page.

What actually changes between stages, and when do most people feel the difference?

Each dose increase brings a stronger signal to both the GIP and GLP-1 receptors. Practically, that tends to mean reduced hunger between meals, a lower tolerance for large portions, and (for most people) a more pronounced slowing of gastric emptying. These effects compound as the dose rises, which is why the greatest weight loss is usually seen at the higher stages rather than early on.

Clinical trial evidence from the SURMOUNT-1 study, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% over 72 weeks at the 15 mg maintenance dose, figures that represent thousands of participants reaching and staying at the highest stage. Not everyone reaches 15 mg; the licensed approach allows for a personal maintenance stage, meaning some people achieve their clinical goals at 10 mg or 12.5 mg and their prescriber may keep them there.

Side effects tend to peak in the days after a dose increase and typically settle within one to two weeks at the new level. Nausea and loose stools are most commonly reported during stage transitions rather than as a constant feature. For a broader picture of what to weigh up at each stage, the disadvantages of Mounjaro page covers the less-discussed aspects honestly.

How does a prescriber decide when to move you to the next stage?

Your prescriber looks at two things: how well you're tolerating the current dose, and whether you're making progress. NICE's appraisal of tirzepatide (TA1026) notes that if someone loses less than 5% of their body weight after six months at the highest tolerated dose, continuing should be reviewed, which means the stages are not just about going up, but about finding the dose that is both tolerable and effective for you specifically.

At a regulated online pharmacy, this review happens before every repeat order. At nume, a GPhC-registered prescriber reads your consultation responses personally on the same day, not a bot, not an automated score. If you're mid-treatment and unsure whether your current stage is right, that is precisely the kind of clinical question our prescribers are there to answer. You can also review current treatment options on the weight-loss treatments page if you're still deciding whether to start.

Supply interruptions can occasionally affect specific strengths, Mounjaro supply shortages have been a real issue at times in the UK, and it's worth knowing how shortages interact with your stage before you're in the middle of one. Your prescriber can advise on the safest approach if your current stage strength is unavailable.

Does moving through the stages mean the side effects get worse?

Not necessarily, and this is a question our prescribers hear most weeks. Side effects are typically most pronounced in the first two weeks at any new dose and then ease as your body recalibrates. By the time you move up again, your system has usually adapted to the previous level. Many people find the later stages no harder to tolerate than the earlier ones, because they've already adjusted to how tirzepatide works in their body.

That said, everyone responds differently. Some people experience a meaningful uptick in nausea at 10 mg or above; others sail through the higher stages without difficulty. The key is not to rush. Staying at a stage for longer than four weeks is clinically valid if side effects are significant, and your prescriber may adjust the schedule accordingly. If you're curious about the physical changes that can accompany treatment, the Mounjaro face images page gives a visual sense of what some people experience as they progress through the stages. If you're interested in what the pen itself looks like at different stages, the Mounjaro images page shows the KwikPen formats in each colour-coded strength.

For anyone who has concerns about a specific side effect or wants to understand the broader risk picture before starting, it's always appropriate to raise those with a prescriber before committing to treatment. The full Mounjaro overview covers eligibility, access routes and the clinical landscape in one place.